Surveys

Hello,

We would like to invite you to participate in a survey aimed at understanding the experiences of people living with Type 2 Diabetes (T2D) in Canada who have been using insulin icodec (Awiqli^®) for at least 3 months.

The goal of this survey is to gather feedback on your satisfaction and perceived convenience of Awiqli^®. In this questionnaire, we will refer to insulin icodec as "Awiqli^®".

The Carenity Team is committed to building a platform that reflects you and your needs. The following survey will allow us to collect your feedback on the Carenity forum and community.